Home / PSYCF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PSYCF make money? Does PSYCF have pricing power? What's the Earnings Whisper? Will PSYCF profit more as the business scales? What is PSYCF's management track record? Is PSYCF's current price justified?

Psyched Wellness Ltd

$0.01 -$0.00 (-37.50%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

$0.01

Day Range

$0.01 - $0.01

Year Range

$0$0.02

Market Cap

1.57M

AVG Volume

109.42K

Trailing/Forward PE

-0.29/-

PEG ratio

0.06

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

PSYCF Revenue (CAD) by year
Period	Revenue (CAD)
2025	472.08K
2024	623.16K
2023	321.1K
2022	14.27K
2021	0
2020	0
2019	0
2018	0
2017	0
2016	0

Net Income (CAD)

PSYCF Net Income (CAD) by year
Period	Net Income (CAD)
2025	-5.03M
2024	-4.26M
2023	-3.43M
2022	-4.3M
2021	-4.5M
2020	-2.07M
2019	-350.12K
2018	-248.39K
2017	-2.48M
2016	-644.59K

Operating Income (CAD)

PSYCF Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	-5.16M
2024	-4.52M
2023	-3.45M
2022	-4.08M
2021	-4.48M
2020	-2.15M
2019	-211.8K
2018	-215.92K
2017	-133.47K
2016	-129.34K

EBITDA (CAD)

PSYCF EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	-5.16M
2024	-4.51M
2023	-3.29M
2022	-1.41M
2021	-39.33K
2020	-2.01M
2019	-275.22K
2018	-218.79K
2017	-2.46M
2016	-628.48K

Cash Flows (CAD)

PSYCF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	-4.05M
2024	-3.1M
2023	-3.11M
2022	-3.18M
2021	-3.04M
2020	-2.31M
2019	-101.49K
2018	-124.31K
2017	-10K
2016	-152.9K

EPS (CAD)

PSYCF EPS (CAD) by year
Period	EPS (CAD)
2025	-0.02
2024	-0.02
2023	-0.03
2022	-0.03
2021	-0.04
2020	-0.03
2019	-0.06
2018	-0
2017	-0.02
2016	-0.01

Expenses (CAD)

PSYCF Expenses (CAD) by year
Period	Expenses (CAD)
2025	5.1M
2024	4.7M
2023	3.47M
2022	4.15M
2021	4.24M
2020	2.09M
2019	174.1K
2018	154.28K
2017	125.4K
2016	145.55K

Cash & Debt (CAD)

PSYCF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	2.25M
2024	6.36M
2023	6.13M
2022	2.57M
2021	5.53M
2020	2.06M
2019	1.47K
2018	55.76K
2017	3.64K
2016	2.14K

Debt ratios

PSYCF Debt ratios by year
Period	Debt ratios
2025	0.16
2024	0.69
2023	0.91
2022	0.69
2021	2.17
2020	0.41
2019	-0.01
2018	-0.17

Margins

PSYCF Margins by year
Period	Margins
2025	18.18%
2024	38.82%
2023	48.49%
2022	52.84%

Return on Capital

PSYCF Return on Capital by year
Period	Return on Capital
2025	-162.32%
2024	-57.28%
2023	-48.8%
2022	-138%
2021	-72.5%
2020	-65.25%
2019	84.45%
2018	31.91%
2017	467.88%
2016	-33.05%

Shares Outstanding

PSYCF Shares Outstanding by year
Period	Shares Outstanding
2025	288.82M
2024	288.07M
2023	153.22M
2022	135.79M
2021	130.59M
2020	104.96M
2019	5.08M
2018	64.75M
2017	126.08M
2016	126.08M

Book Value Per Share (CAD)

PSYCF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	0.01
2024	0.03
2023	0.05
2022	0.02
2021	0.05
2020	0.03
2019	-0.08
2018	-0.01
2017	-0
2016	0.02

Total Assets (CAD)

PSYCF Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	3.75M
2024	7.89M
2023	7.34M
2022	3.31M
2021	6.38M
2020	3.21M
2019	4.78K
2018	137.16K
2017	83.03K
2016	2.4M

Free Cash Flow Yield

PSYCF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-167.11%
Sep 26	-177.78%
Sep 26	-209.45%
Aug 26	-254.25%
Aug 26	-233.46%
Aug 26	-212.32%
Aug 26	-211.35%
Jul 26	-180.18%
Jul 26	-174.18%
Jul 26	-157.57%
Jul 26	-160.11%
Jul 26	-178.03%
Jun 26	-162.4%
Jun 26	-134.42%
Jun 26	-135.85%
Jun 26	-120.76%
May 26	-120.36%
May 26	-112.9%
May 26	-102.13%
May 26	-115.34%
May 26	-114.81%
Apr 26	-126.82%
Apr 26	-102.96%
Apr 26	-126.79%
Apr 26	-124.52%
Mar 26	-109.55%
Mar 26	-102.32%
Mar 26	-127.89%
Mar 26	-107.84%
Feb 26	-89.4%
Feb 26	-115.8%
Feb 26	-81.41%
Feb 26	-117.35%
Jan 26	-99.49%
Jan 26	-92.72%
Jan 26	-87.62%
Jan 26	-87.65%
Jan 26	-111.02%
Dec 25	-81.07%
Dec 25	-67.98%
Dec 25	-63.24%
Dec 25	-80.23%
Nov 25	-59.43%
Nov 25	-64.34%
Nov 25	-49.77%
Nov 25	-67.7%
Oct 25	-67.36%
Oct 25	-60.18%
Oct 25	-60.08%
Oct 25	-64.8%
Oct 25	-62.31%
Sep 25	-67.67%
Sep 25	-53.01%
Sep 25	-58.33%
Sep 25	-66.12%
Aug 25	-71.52%
Aug 25	-61.87%
Aug 25	-59.52%
Aug 25	-59.78%
Aug 25	-59.63%
Jul 25	-35.47%
Jul 25	-56.87%
Jul 25	-39.05%
Jul 25	-43.24%
Jun 25	-52.1%
Jun 25	-43.24%
Jun 25	-63.48%
Jun 25	-56.58%
May 25	-55.58%
May 25	-61.33%
May 25	-56.32%
May 25	-62.39%
May 25	-56.95%
Apr 25	-60.23%
Apr 25	-64.92%
Apr 25	-70.67%
Apr 25	-64.42%
Mar 25	-60.24%
Mar 25	-54.42%
Mar 25	-52.52%
Mar 25	-57.28%
Feb 25	-49.69%
Feb 25	-49.18%
Feb 25	-48.44%
Feb 25	-51.53%
Jan 25	-56.5%
Jan 25	-54.93%
Jan 25	-51.16%
Jan 25	-63.04%
Jan 25	-63.42%
Dec 24	-64.16%
Dec 24	-64.49%
Dec 24	-57.67%
Dec 24	-58.63%
Nov 24	-59.21%
Nov 24	-58.52%
Nov 24	-53.44%
Nov 24	-47.7%
Nov 24	-72.58%
Oct 24	-68.76%

Price to Sales

PSYCF Price to Sales by year
Period	Price to Sales
Sep 26	3.54
Sep 26	3.33
Sep 26	2.83
Aug 26	3.2
Aug 26	3.49
Aug 26	3.83
Aug 26	3.85
Jul 26	4.52
Jul 26	4.67
Jul 26	5.16
Jul 26	5.08
Jul 26	4.57
Jun 26	5.01
Jun 26	6.05
Jun 26	5.99
Jun 26	6.74
May 26	6.76
May 26	7.61
May 26	8.41
May 26	7.45
May 26	7.48
Apr 26	6.77
Apr 26	8.34
Apr 26	6.77
Apr 26	6.9
Mar 26	7.84
Mar 26	8.39
Mar 26	6.72
Mar 26	7.96
Feb 26	10.93
Feb 26	8.44
Feb 26	12
Feb 26	8.33
Jan 26	9.82
Jan 26	10.54
Jan 26	11.15
Jan 26	11.15
Jan 26	8.8
Dec 25	12.05
Dec 25	14.38
Dec 25	15.45
Dec 25	12.18
Nov 25	12.69
Nov 25	11.72
Nov 25	15.15
Nov 25	11.14
Oct 25	11.19
Oct 25	12.53
Oct 25	12.55
Oct 25	11.64
Oct 25	12.1
Sep 25	11.14
Sep 25	14.23
Sep 25	12.93
Sep 25	11.41
Aug 25	10.54
Aug 25	7.35
Aug 25	7.64
Aug 25	7.61
Aug 25	7.62
Jul 25	12.82
Jul 25	7.99
Jul 25	11.64
Jul 25	10.51
Jun 25	8.73
Jun 25	10.51
Jun 25	7.16
Jun 25	8.03
May 25	8.18
May 25	8.12
May 25	8.84
May 25	7.98
May 25	8.75
Apr 25	8.27
Apr 25	7.67
Apr 25	7.05
Apr 25	7.73
Mar 25	8.27
Mar 25	9.15
Mar 25	9.49
Mar 25	8.7
Feb 25	10.03
Feb 25	11.3
Feb 25	11.47
Feb 25	10.78
Jan 25	9.83
Jan 25	10.12
Jan 25	10.86
Jan 25	8.81
Jan 25	8.76
Dec 24	8.66
Dec 24	8.62
Dec 24	9.64
Dec 24	9.48
Nov 24	9.38
Nov 24	11.1
Nov 24	12.16
Nov 24	13.62
Nov 24	8.95
Oct 24	9.45

Price to Book

PSYCF Price to Book by year
Period	Price to Book
Sep 26	1.56
Sep 26	1.47
Sep 26	1.24
Aug 26	1.11
Aug 26	1.21
Aug 26	1.33
Aug 26	1.33
Jul 26	1.57
Jul 26	1.62
Jul 26	1.79
Jul 26	1.76
Jul 26	1.58
Jun 26	1.74
Jun 26	2.1
Jun 26	2.08
Jun 26	2.34
May 26	2.34
May 26	1.16
May 26	1.28
May 26	1.13
May 26	1.14
Apr 26	1.03
Apr 26	1.27
Apr 26	1.03
Apr 26	1.05
Mar 26	1.19
Mar 26	1.28
Mar 26	1.02
Mar 26	1.21
Feb 26	0.91
Feb 26	0.7
Feb 26	1
Feb 26	0.69
Jan 26	0.82
Jan 26	0.88
Jan 26	0.93
Jan 26	0.93
Jan 26	0.73
Dec 25	1
Dec 25	1.2
Dec 25	1.29
Dec 25	1.01
Nov 25	1.07
Nov 25	0.99
Nov 25	1.28
Nov 25	0.94
Oct 25	0.95
Oct 25	1.06
Oct 25	1.06
Oct 25	0.98
Oct 25	1.02
Sep 25	0.94
Sep 25	1.2
Sep 25	1.09
Sep 25	0.96
Aug 25	0.89
Aug 25	0.73
Aug 25	0.76
Aug 25	0.75
Aug 25	0.75
Jul 25	1.27
Jul 25	0.79
Jul 25	1.15
Jul 25	1.04
Jun 25	0.86
Jun 25	1.04
Jun 25	0.71
Jun 25	0.8
May 25	0.81
May 25	0.68
May 25	0.74
May 25	0.67
May 25	0.73
Apr 25	0.69
Apr 25	0.64
Apr 25	0.59
Apr 25	0.65
Mar 25	0.69
Mar 25	0.77
Mar 25	0.79
Mar 25	0.73
Feb 25	0.84
Feb 25	0.88
Feb 25	0.89
Feb 25	0.84
Jan 25	0.76
Jan 25	0.79
Jan 25	0.84
Jan 25	0.68
Jan 25	0.68
Dec 24	0.67
Dec 24	0.67
Dec 24	0.75
Dec 24	0.74
Nov 24	0.73
Nov 24	0.59
Nov 24	0.65
Nov 24	0.72
Nov 24	0.48
Oct 24	0.5

No video analysis for this stock yet. Request one from our team.

News: PSYCF

newsfilecorp.com · 10 Sep 2026

Psyched Wellness Announces Secured Term Loan

Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P.

newsfilecorp.com · 5 Aug 2026

Psyched Wellness Announces Secured Term Loan

Toronto, Ontario--(Newsfile Corp. - August 5, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund III, L.P.

newsfilecorp.com · 29 Jul 2026

Psyched Wellness Launches Strategic Review to Unlock Shareholder Value

Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched Wellness" or the "Company"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that its Board of Directors has commenced a strategic review process designed to evaluate opportunities to enhance and accelerate value creation for shareholders ("Strategic Review").

AI Analysis

Psyched Wellness Ltd

Video analysis: PSYCF

News: PSYCF

Psyched Wellness Announces Secured Term Loan

Psyched Wellness Announces Secured Term Loan

Psyched Wellness Launches Strategic Review to Unlock Shareholder Value

Similar companies